Related Experiment Videos
Neuroblastoma--when are urinary catecholamines and their metabolites 'normal'?
D J Worthington1, E M Hammond, B B Eldeeb
1Department of Clinical Chemistry, Children's Hospital, Birmingham, UK.
Annals of Clinical Biochemistry
|November 1, 1988
Summary
This study establishes urinary reference limits for catecholamines and metabolites in children. Combining total catecholamines and HMMA tests offers high sensitivity for diagnosing neuroblastoma.
Area of Science:
- Pediatric Oncology
- Clinical Chemistry
- Biomarker Discovery
Background:
- Neuroblastoma is characterized by catecholamine overproduction.
- Limited data exist on urinary catecholamine metabolite excretion in pediatric neuroblastoma.
- Accurate diagnostic markers are crucial for early detection.
Purpose of the Study:
- To establish upper reference limits for urinary catecholamines, metadrenalines, and HMMA in children.
- To evaluate the diagnostic performance of these markers for neuroblastoma.
- To optimize biochemical testing strategies for neuroblastoma diagnosis.
Main Methods:
- Determined graphical upper reference limits for urinary catecholamines, metadrenalines, and HMMA relative to creatinine.
- Analyzed data from 174 children with neuroblastoma and 704 hospitalized children with other conditions.
- Calculated sensitivity and specificity for individual and combined marker tests.
Main Results:
- Total catecholamines and HMMA (homovanillic acid) demonstrated the highest diagnostic utility.
- Combining total catecholamines and HMMA achieved 98.8% sensitivity in detecting neuroblastoma.
- Total metadrenalines provided no additional diagnostic information.
Conclusions:
- Urinary total catecholamines and HMMA are effective biomarkers for neuroblastoma diagnosis in children.
- The combination of these two tests significantly enhances diagnostic sensitivity.
- Total metadrenalines can be excluded from routine testing for neuroblastoma.